{"_id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgN79nv8KDA","lastupdate":"2020-12-15T00:00:00.000Z","update_date":"2020-12-15T00:00:00.000Z","lastModified":"Jul 8, 2025","active":1,"confidence_score":91,"confidence_score_reason":"markets, not claimed","urlname":"eximo-medical","minimal_profile":null,"status":"Acquired","fullstatus":"Acquired by AngioDynamics on Oct, 2019","acquired":1,"hide_reason":null,"hide_reason_data":null,"hide_reasons":[{"id":"8257rxn4P8EFQOmS5hAAauHyYMhhxrA5u6yWX4XUShpybX3AMNo3Y9","reason":"Pending approval - External entity"},{"id":"aOIaOiiqfpA8UMw6VCTh8ueRmkG3lzDy1NGqEOaJbe11OrCzMTCCd6","reason":"The company is a service provider"},{"id":"ddgjKuc3GgH8E5UehSVJviRl471BCajL1plO8HtGoOojy2NivYqQ7x","reason":"Owner asked to delete"},{"id":"EjOKM211H1ira9J63oaGPuUxvr7Oba55TZo3NWsFO5uhbNu7o4x4zD","reason":"The company is not Israeli"},{"id":"J7fQJtnT3GdWWSE3MD8rzaW65LJ4jEIKxSZnneQiReONdZjG3zIqWe","reason":"Owner asked to hide in the meantime"},{"id":"NxlAC3ReFb5ksiYNLp2FnUyluoJzwRCYfcF7xpTZaPM53SdWQ5kv0B","reason":"Pending approval"},{"id":"RhC1tlwXzioK0MfzBII3H2wepEfQOfKVktmdwqeqTJjGi3ZaBWUqZo","reason":"The company is not innovative"},{"id":"S0Ed46vNI6vZYVxLedANWGjas23K6hY0QdsCtiGYL7lshqIEdLV3sA","reason":"The company ceased operations in Israel"},{"id":"VTANq7bEvlsEcPjp0ghelXfShaCosgndONGjgU730aAOxXtaDIF5j3","reason":"This is a product of an existing company"}],"type":"Startup","logokey":"$G5dCDyJICGj32lbVJeDGQaPHenRCTDiOpA461A5FuLCOwRGpLiHVyH","name":"Eximo Medical","oneliner":"Hybrid Catheters for Interventional Procedures","registrar":"514804079","website":"https://www.auryon-system.com","careerspage":"","founded_month":7,"founded_year":2012,"formernames":[],"sociallinks":{"twitter":"https://twitter.com/AuryonPad","youtube":"","facebook":"https://www.facebook.com/angiodynamics","linkedin":"https://www.linkedin.com/company/35466312","instagram":""},"social":["https://www.facebook.com/angiodynamics","https://www.linkedin.com/company/35466312","https://twitter.com/AuryonPad"],"flattenedsociallinks":"https://www.facebook.com/angiodynamics|https://www.linkedin.com/company/35466312|https://twitter.com/AuryonPad","apps":{"appstore":"","googleplay":""},"is_claimed_by_owner":null,"employees":"11-50","employees_exact":11,"patent":1,"raised":2521000,"stage":"Acquired","public_stage":"Acquired","primary_sector_key":"agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","primary_sector":"Health Tech & Life Sciences","alternativenames":[""],"about":"Eximo Medical is developing hybrid catheter technology for tissue resection in vascular and gastrointestinal endoluminal applications. The companys proprietary single-use hybrid catheter, Auryon, combines optical fibers that deliver short laser pulses and a blunt mechanical knife.\r\n\r\nThe Auryon system is designed to allow treatment of infrainguinal lesions both above and below the knee (including below the ankle), with a built-in off-centering mechanism for eccentric lesions in the largest catheter. The device includes built-in aspiration to address the risk of embolization.\r\n\r\nAuryon has been tested in a multinational trial in both office-based labs and hospitals.","climatetech_description":null,"is_climatetech_relevant":null,"phone":"+97286307630","country":null,"address":{"israeli":[{"id":"ce7c964e-490a-400e-baff-865a686e734e","city":"Rehovot","type":null,"address":"Prof. Haim Pekeris Street 3, Rehovot, Israel","placeid":null,"notactive":0,"openeddate":null,"registrarid":null,"firstrdcenter":0,"registrarname":null}],"officesabroad":[{"id":"154fbaa3-14df-4542-952d-dec20260f6fc","city":"Saddle Brook","address":"250 Pehle Avenue, Saddle Brook, New Jersey 07663, USA","country":"United States","placeid":null}]},"headquarter_address":null,"district":"Center District","news":[{"id":"711b0b90-0252-4163-b2c1-d3c2d01e5412","date":"Oct 3, 2019","link":"https://en.globes.co.il/en/article-angiodynamics-to-buy-israeli-co-eximo-medical-1001302705","source":"en.globes.co.il","visible":1,"analysis":{"tags":"acquisition","company":"AngioDynamics Inc.","layoffs":null,"summary":"AngioDynamics Inc. has announced its agreement to acquire Eximo Medical Ltd., an Israeli laser technology developer, for $46 million and up to $20 million in milestone payments. Eximo Medical has developed a proprietary 355nm wavelength laser technology platform. The acquisition will bring a foundational technology to AngioDynamics portfolio, changing the way caregivers deliver treatment for peripheral artery disease (PAD). Eximos B-Laser technology offers a differentiated alternative to legacy atherectomy devices, providing safety, precision, and efficiency. The acquisition will enable AngioDynamics to enter a growing market with a breakthrough medical solution. Eximo will continue to operate in Israel. The event occurred on October 3, 2019.","partners":null,"customers":null,"investors":"Accelmed fund, Arkin Holdings, Peregrine Ventures, Tal Capital, Rami Lipman, AMIT, Technion","confidence":9,"key_topics":["medical device","laser technology","acquisition","atherectomy treatment","PAD"],"date_of_event":"2019-10-03","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Acquisition"],"acquisition_amount":"$46 million","structuredIssuesShow":"#Acquisition","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"ld1nMMzbcAtsyME2DgDpsk8iMYvjxF6uicNIAfbJpf0Il6GhfpDD56","news_summary":"AngioDynamics to buy Israeli co Eximo Medical","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"08a3081c-e65d-4b4b-b90d-28aa633d990d","date":"May 16, 2019","link":"https://www.medicaldesignandoutsourcing.com/eximo-medical-launches-b-laser-atherectomy-system/","source":"www.medicaldesignandoutsourcing.com","visible":1,"analysis":{"tags":"medical technology","company":"Eximo Medical","layoffs":null,"summary":"Eximo Medical has launched its B-Laser Atherectomy System for patients with arterial occlusive peripheral arterial disease. The system has shown success in treating complex and calcified lesions, and the company is experiencing commercial progress in the U.S. market. The incorporation of machine learning and photo-acoustic signal monitoring has been beneficial in characterizing materials and preventing complications. Clinicians have expressed excitement about the technology and its potential to address unmet needs in practice.","partners":null,"customers":null,"investors":null,"confidence":8,"key_topics":["B-Laser Atherectomy System","Arterial Occlusive Peripheral Arterial Disease","Machine Learning","Photo-Acoustic Signal Monitoring","Market Progress"],"date_of_event":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Customers","Partners"],"acquisition_amount":null,"structuredIssuesShow":"#Customers  #Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"hUu8syi0sGf5fMFiSAs5FkuvPQnGIDTdtLgiAMJNrqJVgKSPfwkoe4","news_summary":"Eximo Medical launches B-Laser Atherectomy System - Medical Design and Outsourcing","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"a003d64d-f459-468c-b7b2-dafc56290be4","date":"Jan 28, 2019","link":"https://www.businesswire.com/news/home/20190128005571/en/","source":"www.businesswire.com","visible":1,"analysis":{"entityGrowthIconPath":"none;"},"sentiment":null,"analysisId":"oyABL8dKvgmIXoAjjrONvTTsOtLTlaWL7UH96WWvSXe97M79NqoNWX","news_summary":"Eximo Medical Ltd. Announces First Commercial Case of Its B-Laser™ Atherectomy System in the U.S. and Publication of Its IDE and CE Studies Results","analysisStructuredIssuesDisplay":"none","analysisImpactOnCompanyDisplay":"block"},{"id":"ab0977f7-dd26-42d4-be27-2ce726db264c","date":"Oct 12, 2018","link":"https://www.medgadget.com/2018/10/b-laser-the-first-355nm-laser-for-peripheral-artery-disease-cleared-by-fda.html","source":"www.medgadget.com","visible":1,"analysis":{"tags":"FDA clearance","company":"Eximo Medical","layoffs":null,"summary":"Eximo Medical, an Israeli-based company, has received FDA clearance for its B-Laser Atherectomy System. The system is used to clear plaque from narrowed peripheral arteries, including in-stent restenosis. The laser operates at a 355nm wavelength, which the company believes has benefits over commonly used excimer lasers. Clinical trials have shown high success rates and no major adverse events. This FDA clearance is expected to have a positive impact on the growth of Eximo Medical.","partners":null,"customers":null,"investors":null,"confidence":9,"key_topics":["B-Laser Atherectomy System","FDA clearance","Clinical trials","355nm wavelength","Benefits over excimer lasers"],"date_of_event":"October 12th, 2018","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Customers"],"acquisition_amount":null,"structuredIssuesShow":"#Customers","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"CYuwzByAaQ6A2KIdOrONjBHLxGlU4w3fLIqT3ETlwA1m5ghHnN5JLJ","news_summary":"B-Laser, The First 355nm Laser for Peripheral Artery Disease Cleared by FDA","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"2e3fb689-1ddf-45fc-8090-25db5833a763","date":"Apr 6, 2016","link":"http://www.massdevice.com/eximo-medicals-hybrid-catheter-clears-pivotal-trial/","source":"www.massdevice.com","visible":1,"analysis":{"tags":"medical device","company":"Eximo Medical","layoffs":null,"summary":"Eximo Medical has successfully completed a 20-patient pivotal trial in Europe for its hybrid peripheral catheter, meeting safety and efficacy endpoints. The company is pursuing CE Mark approval and plans to seek FDA approval in 2017. The trial demonstrated the devices ability to clear partial or full peripheral blockages. Eximo Medical aims to prevent complicated surgeries and amputations, providing significant pain relief and improving patients quality of life. The successful trial represents a significant milestone for the company and paves the way for a potential multi-participant FDA trial in the United States. Eximo Medical was founded by Accelmed and received a $1.6 million Series A investment round last year.","partners":"Alfred Mann Institute at the Technion, Technion R&D Foundation, private investor","customers":null,"investors":"Accelmed","confidence":9,"key_topics":["CE Mark approval","hybrid peripheral catheter","safety and efficacy endpoints","FDA approval","1st-in-human study"],"date_of_event":"2017","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":"$1.6 million","structured_issues":["Investment","Partners"],"acquisition_amount":null,"structuredIssuesShow":"#Investment  #Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"rRjxQRGYedAl7kZbu0fmpZZxSrg4MYmebTpLmMrj1Ad38rlNMj5H0V","news_summary":"Eximo Medical's hybrid catheter clears pivotal trial","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"04d11e13-ddf9-4ad1-8d70-9ee9c5114fe0","date":"Jul 29, 2015","link":"http://www.globes.co.il/en/article-catheter-developer-eximo-medical-raises-16m-1001056603","source":"www.globes.co.il","visible":1,"analysis":{"tags":"medical device","company":"Eximo Medical","layoffs":null,"summary":"Eximo Medical has completed its Series A financing round of $1.6 million. The funding will be used for human clinical trials of its hybrid catheters. The companys patented Cathi technology combines laser ablation capabilities with a mechanical blunt blade, potentially improving accuracy and precision in treating vessel blockages. The catheters will be tested in human studies in Europe and Israel in the fourth quarter of this year. Eximos product pipeline includes solutions for Lead Extraction and interventional gastrointestinal procedures. The company aims to address the multi-billion market of Peripheral Artery Disease (PAD), which affects millions of Americans and is the underlying cause of limb amputations.","partners":null,"customers":null,"investors":"Accelmed, Alfred Mann Institute at the Technion (AMIT), Technion R&D Foundation Ltd., private investor","confidence":9,"key_topics":["Series A financing","hybrid catheters","human clinical trials","PAD patients","laser system"],"date_of_event":"July 29, 2015","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":"$1.6 million","structured_issues":["Investment","Expand"],"acquisition_amount":null,"structuredIssuesShow":"#Investment  #Expand","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"j5f77UBQMG435AB0Fj4oVLBU51iWOejBdkY3EaR4JsCNWdkg3L96dn","news_summary":"Catheter developer Eximo Medical raises $1.6m","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"}],"newsNumber":6,"techcommunityinvolvement":null,"mediagallery":[{"id":"98485f35-7131-4a4d-8174-c4eb03709b83","timestamp":"2020-12-15 08:58:18.000000","resources_type":1,"resources_title":"","resources_file_name":"$CgCmbhejk3ZOjHaFNERZ7mcsHXtHlZPc23aXIHFgejUe6BI3IKr4UC","alt":"","cleanBucketUrl":"https://storage.googleapis.com/clean-finder-353810","imageurl":"https://storage.googleapis.com/clean-finder-353810/$CgCmbhejk3ZOjHaFNERZ7mcsHXtHlZPc23aXIHFgejUe6BI3IKr4UC","url":"https://storage.googleapis.com/clean-finder-353810/$CgCmbhejk3ZOjHaFNERZ7mcsHXtHlZPc23aXIHFgejUe6BI3IKr4UC"},{"id":"0a228614-cb3e-416a-9b21-9797d48ac281","timestamp":"2020-12-15 08:58:07.000000","resources_type":1,"resources_title":"","resources_file_name":"$b8S4Xz5KFOjyERNYvClKQg68KRfEDsx5C8PI8PNenMlrP7AW81oEL3","alt":"","cleanBucketUrl":"https://storage.googleapis.com/clean-finder-353810","imageurl":"https://storage.googleapis.com/clean-finder-353810/$b8S4Xz5KFOjyERNYvClKQg68KRfEDsx5C8PI8PNenMlrP7AW81oEL3","url":"https://storage.googleapis.com/clean-finder-353810/$b8S4Xz5KFOjyERNYvClKQg68KRfEDsx5C8PI8PNenMlrP7AW81oEL3"}],"tags":["catheters","gastroenterology","vascular","lasers","surgery","medical-devices","healthcare-providers","clinics","doctors","cardiology","hospitals"],"classificationIDs":["agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7rMLDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfQhvYKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Jvz8d0LDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Juzz-kKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA"],"technologysuccessstory":[{"date":"2012-07-01","name":"Innovative Hybrid Catheters For Safe and Precise Interventional Procedures","tags":["vascular","medical-devices","lasers","catheters"],"category":"Medical Devices","tto_logo":"/image_cloud/t3_tto_logo_f5fde2b3-6016-11e8-abf1-41fdcbb0dda6","university_logo":"/image_cloud/t3_institution_logo_f5fde2b3-6016-11e8-abf1-41fdcbb0dda6"}],"usecases":[],"businessmodels":["B2B"],"productstage":"Clinical Trial","products":["Auryon"],"geomarkets":[],"targetmarkets":[],"marketcapital":null,"marketcapitaldate":null,"funding":{"investors":4,"lastfunding":"$1.6M","totalrounds":2,"fundingstage":"Acquired","totalfunding":"$2.52M","publicinvestors":4,"lastpublicfunding":1600000,"totalpublicrounds":2,"totalpublicfunding":2521000},"team":[{"name":"Yoel Zabar","email":"yoelz@eximomedical.com","phone":"","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAgLHb7YEIDA","bounced":false,"claimed":0,"founder":0,"urlname":"yoel-zabar","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgICA8aj85wgM","position":"CEO","last_name":"Zabar","claimtoken":"230ab4c34c3c796c9d38c9f0100c165aa1989e6ab073aff3616958f1d65cf8ac","first_name":"Yoel","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/yoel-zabar-627b4929/","unsubscribed":false,"is_activeuser":0,"additionalemail":"","claimedemaildate":"2020-12-03 12:35:54.000000","initials":"YZ","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Ilan  Ben Oren","email":"ilanbo@eximomedical.com","phone":"","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAoPKGwtAJDA","bounced":true,"claimed":0,"founder":1,"urlname":"ilan-ben-oren-4","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgICg8uKOlgsM","position":"Founder & CTO","last_name":"Ben Oren","claimtoken":"d764513729a126752cc1b3af8dc71c13acf1bd4b807f5aaf0d3b2b1da9c6f0d0","first_name":"Ilan ","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/ilan-ben-oren-53ba1/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2020-12-03 12:35:55.000000","initials":"IB","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Yael Cohen","email":"Yael.Cohen@angiodynamics.com","phone":"","gender":"Female","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAwP6M9ZcKDA","bounced":false,"claimed":0,"founder":0,"urlname":"yael-cohen-10","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgIDA_pLp2gsM","position":"HR Manager","last_name":"Cohen","claimtoken":"0629bef097534562bfe9190979b6b3f5bcb249e37c0c875ed8875a181e076697","first_name":"Yael","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/yaelcohen11/","unsubscribed":false,"is_activeuser":0,"additionalemail":"yaelc@eximomedical.com","claimedemaildate":"2020-12-03 12:35:56.000000","initials":"YC","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""}],"description_edited":1,"tag_line_edited":1,"sector":"Digital Health and Medical Technologies","sectorverify":{"id":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAgN7UwIEIDA","fullname":"Aviv Alper"},"biverify":{"id":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAgMGgoMMJDA","fullname":"Yanina Wainscheinker"},"biverifydate":"2020-03-16T00:00:00.000Z","crunchbaseid":"eximo-medical","lastupdator":"Orli Wollner","lastupdator_email":"orlushka@gmail.com","creator":"Paz Eliav","creator_email":"paze@cet.ac.il","createdate":"2014-11-30T00:00:00.000Z","biverification":"Yanina Wainscheinker","sectorverification":"Aviv Alper","affiliatedOrganizations":null,"timeline":[{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOD2svPCCAw","date":"Oct 2019","amount":"$46M","source":"https://www.angiodynamics.com/news-and-events/91/AngioDynamics-Acquires-Eximo-Medical-Ltd-and-its-Innovative-355nm-Laser-Atherectomy-Technology/","mnatype":"Acquisition","eventtype":"MNAEvent","investment":[],"wasacquired":1,"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":null,"acquiredcompany_mna":"AngioDynamics","acquiredcompany_mna_id":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgODW_7jcCAw","acquiredcompany_mna_type":"Company","acquiredcompany_mna_hidden":true,"acquiredcompany_mna_fullurl":"/company_page/angiodynamics","acquiredcompany_mna_logokey":"$2xfn5hxoJTBuhKtD9IDBhA0oMSfnO59a0pqEWg8enqJZJ0Sn4T3Y1K","acquiredcompany_mna_urlname":"/company_page/angiodynamics","acquiredcompany_mna_homepage":null,"style":"","hiddenCompanyTooltip":"","acquiredcompany_mna_logourl":"https://storage.googleapis.com/clean-finder-353810/$2xfn5hxoJTBuhKtD9IDBhA0oMSfnO59a0pqEWg8enqJZJ0Sn4T3Y1K","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","exit_label":"EXIT","po_label":"Initial Public Offering","acquireddesc":"Was acquired by","sectionname":"Public Offerings & Exit","amountnumber":46000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOD4u5KkCAw","date":"Jul 2015","amount":"$1.6M","source":"Migrated","eventtype":"FundingRoundEvent","investment":[{"name":"Accelmed","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/accelmed","logokey":"$FaEkBoI4nadGPZmOWfS9cEXuO0HvFoMp6AH9slrWmX4uk0dGvZ4xSj","tagline":null,"urlname":"/investor_page/accelmed","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgKmI44gKDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"4a7241a0-0835-49b7-924f-221360ef53b8","fundingsubtype":"VC and Private Equity","investorislead":null,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$FaEkBoI4nadGPZmOWfS9cEXuO0HvFoMp6AH9slrWmX4uk0dGvZ4xSj","leadcaption":"","followupcaption":""},{"name":"AMIT-Technion ( The Alfred Mann Institute)","type":"Company","amount":0,"hidden":true,"country":"Israel","fullurl":"/company_page/amit-technion-the-alfred-mann-institute","logokey":"$xaIv6yseodBT8RCm5EBa6KRdWSlNBvAp6GU5tcYr8byE9pBjAKeSIT","tagline":"Development & Commercialization of Biomedical Innovations Conceived by Technion Researcher","urlname":"/company_page/amit-technion-the-alfred-mann-institute","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgODUpcX1Cgw","fundingtype":"Company","leadpartner":null,"investmentid":"4c89db6d-c49d-4ef2-aea7-c08cb214391c","fundingsubtype":"","investorislead":null,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$xaIv6yseodBT8RCm5EBa6KRdWSlNBvAp6GU5tcYr8byE9pBjAKeSIT","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"A Round","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":1600000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCE7uqOCgw","date":"Oct 2012","amount":"$921K","source":"Migrated, Amit from Peregrine sent a file","eventtype":"FundingRoundEvent","investment":[{"name":"Accel","type":"Investor","amount":0,"hidden":false,"country":"United States","fullurl":"/investor_page/accel-partners","logokey":"$ajrr1RoaTjZL82thTxQurK4NPeeciyRWtW1W4f186EClvTTa1zMXB9","tagline":null,"urlname":"/investor_page/accel-partners","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAwOSKqIQLDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"205fb437-4890-4ecd-a086-2ea94122bd8d","fundingsubtype":"VC and Private Equity","investorislead":null,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$ajrr1RoaTjZL82thTxQurK4NPeeciyRWtW1W4f186EClvTTa1zMXB9","leadcaption":"","followupcaption":""},{"name":"Peregrine Ventures","type":"Investor","amount":921000,"hidden":false,"country":"Israel","fullurl":"/investor_page/peregrine-ventures","logokey":"$T9b3MhmeKbyWXOhmHsdeo59IpRH5j3rFLwfog4x6rVvePI0vqruN3t","tagline":null,"urlname":"/investor_page/peregrine-ventures","isisraeli":1,"investorid":"Y57DaSxuoKU94wasDhLnfv7mvfy2Gyr9ekuOlM6BCGtWak5CprFY2M","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"OPupkOMvQcnGTCNVZiTrw8lrci59LFUy9fNNs2ZBPW1L36qLHqbQe1","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$T9b3MhmeKbyWXOhmHsdeo59IpRH5j3rFLwfog4x6rVvePI0vqruN3t","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Seed","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":921000,"capitalraised":"Undisclosed","valuation":"Undisclosed"}],"investmentstage":[],"exits":[],"investments":[],"portfolio":[],"funds":[],"founded":"7/2012","databases":[],"sharedspaces":[],"utilities":[],"contributors":[],"employeesworldwide":"","fundingtype":"Startup","parsedName":"Eximo Medical","logourl":"https://storage.googleapis.com/clean-finder-353810/$G5dCDyJICGj32lbVJeDGQaPHenRCTDiOpA461A5FuLCOwRGpLiHVyH","oglogourl":"https://storage.googleapis.com/clean-finder-353810/$G5dCDyJICGj32lbVJeDGQaPHenRCTDiOpA461A5FuLCOwRGpLiHVyH","seoabout":"Eximo Medical is developing hybrid catheter technology for tissue resection in vascular and gastrointestinal endoluminal applications. The companys proprie...","seoTitle":"Israeli Startup","solutions":[],"teamMembersNumber":3,"primarySector":"Health Tech & Life Sciences","primary-sector-display":"block","classifications":[{"depth":0,"name":"Sector","queryString":"sectorclassification=undefined","classificationName":"sectorclassification"},{"depth":1,"name":"Health Tech & Life Sciences","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","classificationName":"sectorclassification"},{"depth":2,"name":"Medical Devices","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA","classificationName":"sectorclassification"},{"depth":3,"name":"Medical Treatment & Therapeutics","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfQhvYKDA","classificationName":"sectorclassification"},{"depth":0,"name":"Core Technology","queryString":"coretechnology=undefined","classificationName":"coretechnology"},{"depth":1,"name":"Semiconductors & Electronics","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7rMLDA","classificationName":"coretechnology"},{"depth":0,"name":"Target Customer","queryString":"targetcustomer=undefined","classificationName":"targetcustomer"},{"depth":1,"name":"Healthcare & Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","classificationName":"targetcustomer"},{"depth":2,"name":"Healthcare","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","classificationName":"targetcustomer"},{"depth":3,"name":"Providers","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","classificationName":"targetcustomer"},{"depth":2,"name":"Medical Devices Industry","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Jvz8d0LDA","classificationName":"targetcustomer"},{"depth":3,"name":"Medical Equipment","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Juzz-kKDA","classificationName":"targetcustomer"}],"classificationDelimited":["SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Medical Devices#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA","TechnologyClassificationModel>Semiconductors & Electronics#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7rMLDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Medical Devices#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA>Medical Treatment & Therapeutics#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfQhvYKDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA>Providers#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Medical Devices Industry#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Jvz8d0LDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Medical Devices Industry#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Jvz8d0LDA>Medical Equipment#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Juzz-kKDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA"],"classificationsViewModel":"|0:>SectorClassificationModel|1:>SectorClassificationModel/Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA|2:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA/Medical Devices#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA|3:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Medical Devices#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA/Medical Treatment & Therapeutics#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfQhvYKDA|0:>TechnologyClassificationModel|1:>TechnologyClassificationModel/Semiconductors & Electronics#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7rMLDA|0:>IndustryClassificationModel|1:>IndustryClassificationModel/Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA|2:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA/Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA|3:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA/Providers#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA|2:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA/Medical Devices Industry#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Jvz8d0LDA|3:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Medical Devices Industry#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Jvz8d0LDA/Medical Equipment#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Juzz-kKDA|","classificationTrees":{"sector":[{"title":"Health Tech & Life Sciences","key":"0-0","path":"SectorClassificationModel>Health Tech & Life Sciences","children":[{"title":"Medical Devices","key":"0-0-0","path":"SectorClassificationModel>Health Tech & Life Sciences>Medical Devices","children":[{"title":"Medical Treatment & Therapeutics","key":"0-0-0-0","path":"SectorClassificationModel>Health Tech & Life Sciences>Medical Devices>Medical Treatment & Therapeutics"}]}]}],"targetCustomer":[{"title":"Healthcare & Life Sciences","key":"0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences","children":[{"title":"Healthcare","key":"0-0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences>Healthcare","children":[{"title":"Providers","key":"0-0-0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences>Healthcare>Providers"}]},{"title":"Medical Devices Industry","key":"0-0-1","path":"IndustryClassificationModel>Healthcare & Life Sciences>Medical Devices Industry","children":[{"title":"Medical Equipment","key":"0-0-1-0","path":"IndustryClassificationModel>Healthcare & Life Sciences>Medical Devices Industry>Medical Equipment"}]}]}],"coreTechnology":[{"title":"Semiconductors & Electronics","key":"0-0","path":"TechnologyClassificationModel>Semiconductors & Electronics"}]},"sectorClassifications":[{"depth":0,"name":"Sector","queryString":"sectorclassification=undefined","classificationName":"sectorclassification"},{"depth":1,"name":"Health Tech & Life Sciences","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","classificationName":"sectorclassification"},{"depth":2,"name":"Medical Devices","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA","classificationName":"sectorclassification"},{"depth":3,"name":"Medical Treatment & Therapeutics","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfQhvYKDA","classificationName":"sectorclassification"}],"coreTechnologyClassifications":[{"depth":0,"name":"Core Technology","queryString":"coretechnology=undefined","classificationName":"coretechnology"},{"depth":1,"name":"Semiconductors & Electronics","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7rMLDA","classificationName":"coretechnology"}],"targetCustomerClassifications":[{"depth":0,"name":"Target Customer","queryString":"targetcustomer=undefined","classificationName":"targetcustomer"},{"depth":1,"name":"Healthcare & Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","classificationName":"targetcustomer"},{"depth":2,"name":"Healthcare","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","classificationName":"targetcustomer"},{"depth":3,"name":"Providers","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","classificationName":"targetcustomer"},{"depth":2,"name":"Medical Devices Industry","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Jvz8d0LDA","classificationName":"targetcustomer"},{"depth":3,"name":"Medical Equipment","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Juzz-kKDA","classificationName":"targetcustomer"}],"classificationNames":{"sector":["Health Tech & Life Sciences","Medical Devices","Medical Treatment & Therapeutics"],"coreTechnology":["Semiconductors & Electronics"],"targetCustomer":["Healthcare & Life Sciences","Healthcare","Providers","Medical Devices Industry","Medical Equipment"]},"section":null,"sectionParams":"","queryParams":"","popup_claim_profile":"false","claimedBadge":"none","display":{"mainContact":"none","climateTag":"none","seeMoreSimilarCompanisDisplay":"none","similarCompaniesTitleFontSize":"3.2rem","similarCompaniesTitle":"Similar Companies","similar_companies":[]},"mainContact":{},"_eventview":{"publicoffering_exit":[{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOD2svPCCAw","date":"Oct 2019","amount":"$46M","source":"https://www.angiodynamics.com/news-and-events/91/AngioDynamics-Acquires-Eximo-Medical-Ltd-and-its-Innovative-355nm-Laser-Atherectomy-Technology/","mnatype":"Acquisition","eventtype":"MNAEvent","investment":[],"wasacquired":1,"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":null,"acquiredcompany_mna":"AngioDynamics","acquiredcompany_mna_id":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgODW_7jcCAw","acquiredcompany_mna_type":"Company","acquiredcompany_mna_hidden":true,"acquiredcompany_mna_fullurl":"/company_page/angiodynamics","acquiredcompany_mna_logokey":"$2xfn5hxoJTBuhKtD9IDBhA0oMSfnO59a0pqEWg8enqJZJ0Sn4T3Y1K","acquiredcompany_mna_urlname":"/company_page/angiodynamics","acquiredcompany_mna_homepage":null,"style":"","hiddenCompanyTooltip":"","acquiredcompany_mna_logourl":"https://storage.googleapis.com/clean-finder-353810/$2xfn5hxoJTBuhKtD9IDBhA0oMSfnO59a0pqEWg8enqJZJ0Sn4T3Y1K","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","exit_label":"EXIT","po_label":"Initial Public Offering","acquireddesc":"Was acquired by","sectionname":"Public Offerings & Exit","amountnumber":46000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"}],"privateequityfunding":[{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOD4u5KkCAw","date":"Jul 2015","amount":"$1.6M","source":"Migrated","eventtype":"FundingRoundEvent","investment":[{"name":"Accelmed","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/accelmed","logokey":"$FaEkBoI4nadGPZmOWfS9cEXuO0HvFoMp6AH9slrWmX4uk0dGvZ4xSj","tagline":null,"urlname":"/investor_page/accelmed","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgKmI44gKDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"4a7241a0-0835-49b7-924f-221360ef53b8","fundingsubtype":"VC and Private Equity","investorislead":null,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$FaEkBoI4nadGPZmOWfS9cEXuO0HvFoMp6AH9slrWmX4uk0dGvZ4xSj","leadcaption":"","followupcaption":""},{"name":"AMIT-Technion ( The Alfred Mann Institute)","type":"Company","amount":0,"hidden":true,"country":"Israel","fullurl":"/company_page/amit-technion-the-alfred-mann-institute","logokey":"$xaIv6yseodBT8RCm5EBa6KRdWSlNBvAp6GU5tcYr8byE9pBjAKeSIT","tagline":"Development & Commercialization of Biomedical Innovations Conceived by Technion Researcher","urlname":"/company_page/amit-technion-the-alfred-mann-institute","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgODUpcX1Cgw","fundingtype":"Company","leadpartner":null,"investmentid":"4c89db6d-c49d-4ef2-aea7-c08cb214391c","fundingsubtype":"","investorislead":null,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$xaIv6yseodBT8RCm5EBa6KRdWSlNBvAp6GU5tcYr8byE9pBjAKeSIT","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"A Round","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":1600000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCE7uqOCgw","date":"Oct 2012","amount":"$921K","source":"Migrated, Amit from Peregrine sent a file","eventtype":"FundingRoundEvent","investment":[{"name":"Accel","type":"Investor","amount":0,"hidden":false,"country":"United States","fullurl":"/investor_page/accel-partners","logokey":"$ajrr1RoaTjZL82thTxQurK4NPeeciyRWtW1W4f186EClvTTa1zMXB9","tagline":null,"urlname":"/investor_page/accel-partners","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAwOSKqIQLDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"205fb437-4890-4ecd-a086-2ea94122bd8d","fundingsubtype":"VC and Private Equity","investorislead":null,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$ajrr1RoaTjZL82thTxQurK4NPeeciyRWtW1W4f186EClvTTa1zMXB9","leadcaption":"","followupcaption":""},{"name":"Peregrine Ventures","type":"Investor","amount":921000,"hidden":false,"country":"Israel","fullurl":"/investor_page/peregrine-ventures","logokey":"$T9b3MhmeKbyWXOhmHsdeo59IpRH5j3rFLwfog4x6rVvePI0vqruN3t","tagline":null,"urlname":"/investor_page/peregrine-ventures","isisraeli":1,"investorid":"Y57DaSxuoKU94wasDhLnfv7mvfy2Gyr9ekuOlM6BCGtWak5CprFY2M","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"OPupkOMvQcnGTCNVZiTrw8lrci59LFUy9fNNs2ZBPW1L36qLHqbQe1","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$T9b3MhmeKbyWXOhmHsdeo59IpRH5j3rFLwfog4x6rVvePI0vqruN3t","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Seed","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":921000,"capitalraised":"Undisclosed","valuation":"Undisclosed"}],"nonequityfunding":[],"merger_acquisitions":[],"others":[]}}